BNTX - Pfizer raises guidance amid cost savings
2024-05-01 08:37:31 ET
More on Pfizer
- Is 7%-Yielding Pfizer Stock A Buy On The Dip Before Q1?
- Unveiling Pfizer's Potent Cocktail: Key Drivers Of Free Cash Flow Growth
- Pfizer's Doldrums, Just A Bad Case Of COVID-19?
- Pfizer beats top-line and bottom-line estimates; reaffirms FY24 outlook
- Pfizer plans direct-to-consumer platform to sell Covid, migraine drugs - report